MLYS

NASDAQ · Biotechnology

Mineralys Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$24.07

+0.79 (+3.39%)

As of Mar 22, 10:02 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 13 87%

Hold 2 13%

Sell 0 0%

Price Target

Analyst Price Target +287.2% upside

Low Target $50.31

Average Target $93.19

High Target $121.15

Current Price $24.07

Current
$24.07

Target
$93.19

$50.31 $93.19 avg $121.15

Scenario Analysis

Bear Case

$50.31

109.0%

Low target

Base Case

$93.19

+287.2%

Avg target

Bull Case

$121.15

+403.3%

High target

Risk/Reward

3.7x

Highly favorable

Price in Context

52-Week High

$47.65

-49.5% from high

52-Week Low

$8.24

+192.1% from low

50-Day SMA

$33.44

-28.0% vs SMA

200-Day SMA

$27.93

-13.8% vs SMA

RSI (14)

35.0

Neutral

Target vs 52W High

$93.19

+95.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+25.5%
AMGN Amgen Inc	Hold	42	50%	$190.87	-45.2%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-66.8%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	+3.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-26.5%